课题基金 / 基金详情

Dosimetry for molecular radiotherapy treatment planning (Stage 1 - no 23440)

Dosimetry for molecular radiotherapy treatment planning (Stage 1 - no 23440)
分子放射治疗治疗计划的剂量测定(第 1 阶段 - 编号 23440)
批准号:
104958
负责人:
金额:
$4.11万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Molecular radiotherapy (MRT) is a treatment modality for cancer. It involves the administration of radioactive atoms with the aim of locally irradiating tumours. Dosimetry is concerned with the measurement of the absorbed radiation dose to each disease site. Many of the treatments in MRT are currently prescribed empirically or with a fixed quantity of radioactivity, without adequate dosimetry. This can lead to suboptimal treatment planning and patient over-exposure to radiation.The goal of this project is to develop a prototype software package for organ-level dosimetry, with the aim of improving treatment efficacy by optimization and personalisation of the administered dose. MRT treatments that are dosimetry-led are expected to produce improved outcomes - improved tumour control, longer survival, reduced symptoms and lower toxicities. Furthermore, patients who are unlikely to respond well to the treatment could be identified in advance, sparing them from unnecessary treatment and potential complications, as well as reducing the financial impact of these relatively high-cost treatments on the healthcare system. Our ultimate aim is to facilitate the wider implementation of dosimetry for molecular radiotherapy as to help improve cancer outcomes within the NHS."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: